Total (62) | D3 (11) | D4 (51) | |
---|---|---|---|
Premier | 1 (1.61 %) | 1 (9.09 %) | |
Deuxième | |||
Troisième |
Eq | Saison | Div | Tour | Match | Neg | Plc | IC | ADV |
---|---|---|---|---|---|---|---|---|
PHEb | 2021 | 3 | 2 | PHEb(27.0)-REC(28.0) | -220 | 1 | 10.0 | 0.0 |
PHEb | 2021 | 3 | 1 | PHEb(37.0)-QUA(18.0) | -188 | 5 | 5.5 | 1.0 |
PHEb | 2020 | 4 | 7 | PHEb(29.0)-SABd(25.0) | -314 | 8 | 3.0 | 3.0 |
PHEb | 2020 | 4 | 5 | PHEb(31.0)-STAb(24.0) | -191 | 8 | 3.0 | 3.0 |
PHEb | 2020 | 4 | 4 | PHEb(21.5)-SABc(33.5) | -285 | 10 | 1.0 | 5.0 |
PHE | 2019 | 3 | 10 | PHE(39.0)-YODc(39.0) | -158 | 12 | 1.0 | 6.0 |
PHE | 2019 | 3 | 9 | REC(36.0)-PHE(42.0) | -330 | 12 | 1.0 | 6.0 |
PHE | 2019 | 3 | 7 | STA(34.0)-PHE(44.0) | -153 | 11 | 2.0 | 6.0 |
PHE | 2019 | 3 | 6 | PHE(40.0)-KAA(38.0) | -237 | 10 | 2.5 | 5.0 |
PHE | 2019 | 3 | 5 | YODc(36.0)-PHE(42.0) | -194 | 12 | 1.0 | 6.0 |
PHE | 2019 | 3 | 4 | PHE(42.0)-REC(36.0) | -374 | 12 | 1.0 | 6.0 |
PHE | 2019 | 3 | 3 | SABc(41.0)-PHE(37.0) | -281 | 11 | 2.0 | 5.0 |
PHE | 2019 | 3 | 2 | PHE(47.0)-STA(31.0) | -272 | 10 | 3.0 | 4.0 |
PHE | 2019 | 3 | 1 | KAA(38.0)-PHE(40.0) | -253 | 10 | 3.0 | 5.0 |
PHEb | 2018 | 4 | 10 | YODd(26.0)-PHEb(29.0) | -296 | 9 | 2.0 | 4.0 |
PHEb | 2018 | 4 | 9 | PHEb(32.0)-QUAb(22.0) | -194 | 4 | 7.0 | 1.0 |
PHEb | 2018 | 4 | 7 | QUAb(24.0)-PHEb(25.0) | -381 | 4 | 7.0 | 1.0 |
PHEb | 2018 | 4 | 6 | SABd(35.0)-PHEb(17.0) | -326 | 7 | 4.0 | 4.0 |
PHEb | 2018 | 4 | 5 | PHEb(28.0)-YODc(27.0) | -293 | 9 | 2.0 | 4.0 |
PHEb | 2018 | 4 | 3 | RECb(29.0)-PHEb(26.0) | -341 | 10 | 1.0 | 5.0 |
PHEb | 2018 | 4 | 2 | PHEb(29.0)-YODd(26.0) | -199 | 8 | 3.0 | 3.0 |
PHEb | 2017 | 4 | 10 | PHEb(30.0)-YODc(25.0) | -330 | 9 | 2.0 | 4.0 |
PHEb | 2017 | 4 | 9 | QUAb(27.0)-PHEb(28.0) | -354 | 8 | 3.0 | 3.0 |
PHEb | 2017 | 4 | 8 | QUAa(35.0)-PHEb(20.0) | -174 | 8 | 3.0 | 4.0 |
PHEb | 2017 | 4 | 6 | PHEb(17.0)-KAAb(37.0) | -359 | 8 | 3.0 | 5.0 |
PHEb | 2017 | 4 | 3 | PHEb(24.0)-QUAb(31.0) | -310 | 8 | 3.0 | 4.0 |
PHEb | 2017 | 4 | 2 | PHEb(35.0)-SABe(20.0) | -331 | 7 | 4.0 | 2.0 |
PHEb | 2017 | 4 | 1 | RECb(29.0)-PHEb(26.0) | -290 | 10 | 1.0 | 5.0 |
PHEb | 2016 | 4 | 11 | PHEb(28.5)-RECb(26.5) | -275 | 7 | 4.0 | 3.0 |
PHEb | 2016 | 4 | 10 | YODb(30.0)-PHEb(25.0) | -232 | 8 | 3.0 | 5.0 |
PHEb | 2016 | 4 | 9 | PHEb(32.5)-SABd(22.5) | -102 | 4 | 6.5 | 1.5 |
PHEb | 2016 | 4 | 8 | PHEb(18.5)-QUAb(33.5) | -142 | 4 | 6.5 | 2.5 |
PHEb | 2016 | 4 | 6 | RECb(31.0)-PHEb(23.0) | -292 | 6 | 5.0 | 3.0 |
PHEb | 2016 | 4 | 4 | PHEb(17.0)-YODb(38.0) | -226 | 10 | 1.0 | 5.0 |
PHEb | 2016 | 4 | 3 | SABd(23.0)-PHEb(32.0) | -248 | 7 | 4.0 | 2.0 |
PHEb | 2016 | 4 | 2 | QUAb(24.0)-PHEb(31.0) | -330 | 8 | 3.0 | 3.0 |
PHEb | 2015 | 4 | 11 | PHEb(26.0)-RECa(29.0) | -205 | 8 | 3.0 | 4.0 |
PHEb | 2015 | 4 | 10 | SABd(29.0)-PHEb(26.0) | -319 | 8 | 3.0 | 4.0 |
PHEb | 2015 | 4 | 8 | PHEb(17.0)-RECb(38.0) | -241 | 8 | 3.0 | 5.0 |
PHEb | 2015 | 4 | 7 | PHEb(31.0)-KAKc(24.0) | -265 | 7 | 4.0 | 2.0 |
PHEb | 2015 | 4 | 5 | RECa(27.0)-PHEb(28.0) | -204 | 9 | 2.0 | 4.0 |
PHEb | 2015 | 4 | 4 | PHEb(31.0)-SABd(23.0) | -192 | 7 | 4.0 | 3.0 |
PHEb | 2015 | 4 | 3 | PHEb(23.0)-YODb(32.0) | -298 | 8 | 3.0 | 4.0 |
PHEb | 2015 | 4 | 2 | RECb(31.0)-PHEb(24.0) | -272 | 8 | 3.0 | 4.0 |
PHEb | 2015 | 4 | 1 | KAKc(28.0)-PHEb(27.0) | -341 | 10 | 1.0 | 5.0 |
PHEb | 2014 | 4 | 10 | KIH(25.0)-PHEb(30.0) | -249 | 9 | 2.0 | 4.0 |
PHEb | 2014 | 4 | 9 | PHEb(20.0)-STA(35.0) | -255 | 10 | 1.0 | 5.0 |
PHEb | 2014 | 4 | 8 | RECa(35.0)-PHEb(19.0) | -292 | 9 | 2.0 | 5.0 |
PHEb | 2014 | 4 | 7 | PHEb(17.0)-SABc(38.0) | -328 | 8 | 3.0 | 5.0 |
PHEb | 2014 | 4 | 6 | KAKb(18.0)-PHEb(37.0) | -285 | 8 | 3.0 | 3.0 |
PHEb | 2014 | 4 | 5 | PHEb(23.0)-KIH(32.0) | -197 | 9 | 2.0 | 5.0 |
PHEb | 2014 | 4 | 4 | STA(35.0)-PHEb(20.0) | -227 | 10 | 1.0 | 5.0 |
PHEb | 2014 | 4 | 3 | PHEb(28.5)-RECa(26.5) | -208 | 9 | 2.0 | 4.0 |
PHEb | 2014 | 4 | 2 | SABc(32.0)-PHEb(23.0) | -196 | 10 | 1.0 | 5.0 |
PHEb | 2014 | 4 | 1 | PHEb(31.0)-KAKb(24.0) | -354 | 9 | 2.0 | 4.0 |
PHEb | 2013 | 4 | 10 | QUAb(20.0)-PHEb(34.0) | -218 | 4 | 7.0 | 1.0 |
PHEb | 2013 | 4 | 9 | PHEb(25.0)-ASS(30.0) | -203 | 6 | 5.0 | 3.0 |
PHEb | 2013 | 4 | 8 | CINb(25.0)-PHEb(30.0) | -211 | 5 | 6.0 | 2.0 |
PHEb | 2013 | 4 | 7 | PHEb(25.0)-KIH(29.0) | -273 | 9 | 2.0 | 5.0 |
PHEb | 2013 | 4 | 6 | KAKb(32.0)-PHEb(23.0) | -132 | 7 | 4.0 | 4.0 |
PHEb | 2013 | 4 | 4 | ASS(25.0)-PHEb(30.0) | -177 | 7 | 4.0 | 3.0 |
PHEb | 2013 | 4 | 2 | KIH(30.0)-PHEb(25.0) | -264 | 8 | 3.0 | 4.0 |